Современные представления об эпидемиологии, клинико-патогенезу, иммунопатологии, дополнительных факторах поддержания воспаления, диагностике, лечению COVID-19 в условиях Высокогорья (обзор литературы)

59. Rahman, S., Montero, M.T.V., Rowe, K., Kirton, R., & Kunik Jr, F. (2021). Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert review of clinical pharmacology, 14 (5), 601-621. https://doi.org/10.1080/17512433.2021.1902303

60. Bustin, S.A., & Mueller, R. (2005). Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis. Clinical Science, 109 (4), 365-379. https://doi.org/10.1042/CS20050086

61. Tang, Y.W., Schmitz, J.E., Persing, D.H., & Stratton, C.W. (2020). Laboratory diagnosis of COVID-19: current issues and challenges. Journal of clinical microbiology, 58 (6), 10-1128. https://doi.org/10.1128/jcm.00512-20

62. Peeling, R.W., Wedderburn, C.J., Garcia, P.J., Boeras, D., Fongwen, N., Nkengasong, J.,… & Heymann, D.L. (2020). Serology testing in the COVID-19 pandemic response. The Lancet Infectious Diseases, 20 (9), e245-e249. https://doi.org/10.1016/S1473-3099 (20) 30517-X

63. Freeman, B., Lester, S., Mills, L., Rasheed, M.A.U., Moye, S., Abiona, O.,… & Thornburg, N.J. (2020). Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillance. Biorxiv. https://doi.org/10.1101% 2F2020.04.24.057323

64. Ospina-Tascon, G.A., Calderon-Tapia, L.E., Garcia, A.F., Zarama, V., Gomez-Alvarez, F., Alvarez-Saa, T.,… & HiFLo-Covid Investigators. (2021). Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a randomized clinical trial. Jama, 326 (21), 2161-2171. https://doi.org/10.1001/jama.2021.20714

65. Carfi, A., Bernabei, R., & Landi, F. (2020). Persistent symptoms in patients after acute COVID-19. Jama, 324 (6), 603-605. https://doi.org/10.1001/jama.2020.12603

66. Halpin, S.J., McIvor, C., Whyatt, G., Adams, A., Harvey, O., McLean, L.,… & Sivan, M. (2021). Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. Journal of medical virology, 93 (2), 1013-1022. https://doi.org/10.1002/jmv.26368

67. Bowles, K.H., McDonald, M., Barron, Y., Kennedy, E., O'Connor, M., & Mikkelsen, M. (2021). Surviving COVID-19 after hospital discharge: symptom, functional, and adverse outcomes of home health recipients. Annals of internal medicine, 174 (3), 316-325. https://doi.org/10.7326/M20-5206

68. Wilder-Smith, A., & Freedman, D.O. (2020). Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. Journal of travel medicine, 27 (2), taaa020. https://doi.org/10.1093/jtm/taaa020

69. Guner, H.R., Hasanoglu, І., & Akta§, F. (2020). COVID-19: Prevention and control measures in community. Turkish Journal of medical sciences, 50 (9), 571-577. https://doi.org/10.3906/sag-2004-146

70. Cirrincione, L., Plescia, F., Ledda, C., Rapisarda, V., Martorana, D., Moldovan, R.E.,… & Cannizzaro, E. (2020). COVID-19 pandemic: Prevention and protection measures to be adopted at the workplace. Sustainability, 12 (9), 3603. https://doi.org/10.3390/su12093603

71. Yao, J.S., Paguio, J.A., Dee, E.C., Tan, H.C., Moulick, A., Milazzo, C.,… & Celi, L.A. (2021). The minimal effect of zinc on the survival of hospitalized patients with COVID-19: an observational study. Chest, 159 (1), 108-111. https://doi.org/10.1016/j.chest.2020.06.082

72. Krause, P., Fleming, T.R., Longini, I., Henao-Restrepo, A.M., Peto, R., Dean, N.E.,… & Henao-Restrepo, A.M. (2020). COVID-19 vaccine trials should seek worthwhile efficacy. The Lancet, 396 (10253), 741-743. https://doi.org/10.1016/S0140-6736 (20) 31821-3

73. Koo, J.R., Cook, A.R., Park, M., Sun, Y., Sun, H., Lim, J.T.,… & Dickens, B.L. (2020). Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study. The Lancet Infectious Diseases, 20 (6), 678-688. https://doi.org/10.1016/S1473-3099 (20) 30162-6

74. Rodriguez-Morales, A.J., Cardona-Ospina, J.A., Gutidrrez-Ocampo, E., Villamizar-Pena, R., Holguin-Rivera, Y., Escalera-Antezana, J.P.,… & Sah, R. (2020). Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel medicine and infectious disease, 34, 101623. https://doi.org/10.1016/jztmaid.2020.101623

75. Shim, E., Tariq, A., Choi, W., Lee, Y., & Chowell, G. (2020). Transmission potential and severity of COVID-19 in South Korea. International Journal of Infectious Diseases, 93, 339-344. https://doi.org/10.1016/_j.ijid.2020.03.031

76. Bavli, I., Sutton, B., & Galea, S. (2020). Harms of public health interventions against covid-19 must not be ignored. Bmj, 371. https://doi.org/10.1136/bmj.m4074

77. Iwasaki, A., & Grubaugh, N.D. (2020). Why does Japan have so few cases of COVID - 19?. EMBO molecular medicine, 12 (5), e12481. https://doi.org/10.15252/emmm.202012481

78. Felsenstein, S., Herbert, J.A., McNamara, P.S., & Hedrich, C.M. (2020). COVID-19: Immunology and treatment options. Clinical immunology, 215, 108448. https://doi.org/10.1016/j.clim.2020.108448

79. Vabret, N., Britton, G.J., Gruber, C., Hegde, S., Kim, J., Kuksin, M.,… & Laserson, U. (2020). Immunology of COVID-19: current state of the science. Immunity, 52 (6), 910-941. https://doi.org/10.1016/jjmmuni.2020.05.002

80. Chuan, Q., Luoqi, Z., Ziwei, H., Shuoqi, Z., Sheng, Y., Yu, T.,… & Dai-Shi, T. (2020). Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis, 10.

81. Tan, M., Liu, Y., Zhou, R., Deng, X., Li, F., Liang, K., & Shi, Y. (2020). Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China. Immunology, 160 (3), 261-268. https://doi.org/10.1111/imm.13223

82. Diao, B., Wang, C., Tan, Y., Chen, X., Liu, Y., Ning, L.,… & Chen, Y. (2020). Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Frontiers in immunology, 827. https://doi.org/10.3389/fimmu.2020.00827

83. Wan, S., Xiang, Y.I., Fang, W., Zheng, Y., Li, B., Hu, Y.,… & Yang, R. (2020). Clinical features and treatment of COVID-19 patients in northeast Chongqing. Journal of medical virology, 92 (7), 797-806. https://doi.org/10.1002/jmv.25783

84. Haveri, A., Smura, T., Kuivanen, S., Osterlund, P., Hepojoki, J., Ikonen, N.,… & Savolainen-Kopra, C. (2020). Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020. Eurosurveillance, 25 (11), 2000266. https://doi.org/10.2807/1560-7917.ES.2020.25.11.2000266

85. Lou, B., Li, T.D., Zheng, S.F., Su, Y.Y., Li, Z.Y., Liu, W.,… & Chen, Y. (2020). Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset. European Respiratory Journal, 56 (2). https://doi.org/10.1183/13993003.00763-2020

86. Wu, Y.C., Chen, C.S., & Chan, Y.J. (2020). The outbreak of COVID-19: An overview. Journal of the Chinese medical association, 83 (3), 217. https://doi.org/10.1097% 2FJCMA.0000000000000270

87. McGonagle, D., Sharif, K., O'Regan, A., & Bridgewood, C. (2020). The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmunity reviews, 19 (6), 102537. https://doi.org/10.1016/j.autrev.2020.102537

88. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y.,… & Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395 (10223), 497-506. https://doi.org/10.1016/S0140-6736 (20) 30183-5

89. Wang, F., Nie, J., Wang, H., Zhao, Q., Xiong, Y., Deng, L.,… & Zhang, Y. (2020). Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. The Journal of infectious diseases, 221 (11), 1762-1769. https://doi.org/10.1093/infdis/jiaa150

90. Tufan, A., Guler, A.A., & Matucci-Cerinic, M. (2020). COVID-19, immune system response, hyperinflammation and repurposingantirheumatic drugs. Turkish journal of medical sciences, 50 (9), 620-632. https://doi.org/10.3906/sag-2004-168

91. Crayne, C.B., Albeituni, S., Nichols, K.E., & Cron, R.Q. (2019). The immunology of macrophage activation syndrome. Frontiers in immunology, 10, 119. https://doi.org/10.3389/fimmu.2019.00119

92. Anka, A.U., Tahir, M.I., Abubakar, S.D., Alsabbagh, M., Zian, Z., Hamedifar, H.,… & Azizi, G. (2021). Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management. Scandinavian journal of immunology, 93 (4), e12998. https://doi.org/10.1111/sji.12998

93. Ye, Q., Wang, B., & Mao, J. (2020). The pathogenesis and treatment of theCytokine Storm'in COVID-19. Journal of infection, 80 (6), 607-613. https://doi.org/10.1016/j.jinf.2020.03.037

94. Law, H.K., Cheung, C.Y., Ng, H.Y., Sia, S.F., Chan, Y.O., Luk, W.,… & Lau, Y.L. (2005). Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood, 106 (7), 2366-2374. https://doi.org/10.1182/blood-2004-10-4166

95. Tynell, J., Westenius, V., Ronkko, E., Munster, V.J., Melen, K., Osterlund, P., & Julkunen, I. (2016). Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells. The Journal of general virology, 97 (Pt 2), 344. https://doi.org/10.1099% 2Fjgv.0.000351

96. Scheuplein, V.A., Seifried, J., Malczyk, A.H., Miller, L., Hocker, L., Vergara-Alert, J.,… & Muhlebach, M.D. (2015). High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus. Journal of virology, 89 (7), 3859-3869. https://doi.org/10.1128/jvi.03607-14

97. Kim, E.S., Choe, P.G., Park, W.B., Oh, H.S., Kim, E.J., Nam, E.Y.,… & Oh, M.D. (2016). Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection. Journal of Korean medical science, 31 (11), 1717-1725. https://doi.org/10.3346/jkms.2016.31.11.1717

98. Wang, C.H., Liu, C.Y., Wan, Y.L., Chou, C.L., Huang, K.H., Lin, H.C.,… & Kuo, H.P. (2005). Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS. Respiratory research, 6, 1-12. https://doi.org/10.1186/1465-9921-6-42

99. Garcia-Sastre, A., & Biron, C.A. (2006). Type 1 interferons and the virus-host relationship: a lesson in detente. Science, 312 (5775), 879-882. https://doi.org/10.1126/science.1125676

100. Channappanavar, R., Fehr, A.R., Zheng, J., Wohlford-Lenane, C., Abrahante, J.E., Mack, M.,… & Perlman, S. (2019). IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. The Journal of clinical investigation, 129 (9), 3625-3639. https://doi.org/10.1172/JCI126363

101. Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M. (2020). The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system. Cytokine & growth factor reviews, 53, 25-32. https://doi.org/10.1016/j.cytogfr.2020.05.003

102. Channappanavar, R., Fehr, A.R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D.K., & Perlman, S. (2016). Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell host & microbe, 19 (2), 181193. http://dx.doi.org/10.1016/j.chom.2016.01.007

103. Hogner, K., Wolff, T., Pleschka, S., Plog, S., Gruber, A.D., Kalinke, U.,… & Herold, S. (2013). Macrophage-expressed IFN-P contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS pathogens, 9 (2), e1003188. https://doi.org/10.1371/journal.ppat.1003188

104. Rodrigue-Gervais, I.G., ЬаЬЬё, K., Dagenais, M., Dupaul-Chicoine, J., Champagne, C., Morizot, A.,… & Saleh, M. (2014). Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival. Cell host & microbe, 15 (1), 23-35. http://dx.doi.org/10.1016% 2Fj.chom.2013.12.003

105. Wu, F., Zhao, S., Yu, B., Chen, Y.M., Wang, W., Song, Z.G.,… & Zhang, Y.Z. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579 (7798), 265269. https://doi.org/10.1038/s41586-020-2008-3

106. Du, Y., Tu, L., Zhu, P., Mu, M., Wang, R., Yang, P.,… & Xu, G. (2020). Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study. American journal of respiratory and critical care medicine, 201 (11), 1372-1379. https://doi.org/10.1164/rccm.202003-0543OC

107. Cao, X. (2020). COVID-19: immunopathology and its implications for therapy. Nature reviews immunology, 20 (5), 269-270. https://doi.org/10.1038/s41577-020-0308-3

108. Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C.,… & Wang, F.S. (2020). Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet respiratory medicine, 8 (4), 420-422. https://doi.org/10.1016/S2213-2600 (20) 30076-X

109. Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J.,… & Peng, Z. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama, 323 (11), 1061-1069. https://doi.org/10.1001/jama.2020.1585

110. Li, Y.X., Wu, W., Yang, T., Zhou, W., Fu, Y.M., Feng, Q.M., & Ye, J.M. (2020). Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19. Zhonghua nei ke za zhi, 59 (5), 372-374. https://doi.org/10.3760/cmaj.cn112138-20200221-00114

111. Lindsley, A.W., Schwartz, J.T., & Rothenberg, M.E. (2020). Eosinophil responses during COVID-19 infections and coronavirus vaccination. Journal of Allergy and Clinical Immunology, 146 (1), 1-7. https://doi.org/10.1016% 2Fj.jaci.2020.04.021

112. Tabachnikova, A., & Chen, S.T. (2020). Roles for eosinophils and basophils in COVID - 19?. Nature Reviews Immunology, 20 (8), 461-461. https://doi.org/10.1038/s41577-020-0379-1

113. Xiang-Hua, Y., Le-Min, W., Ai-Bin, L., Zhu, G., Riquan, L., Xu-You, Z.,… & Ye-Nan, W. (2010). Severe acute respiratory syndrome and venous thromboembolism in multiple organs. American journal of respiratory and critical care medicine, 182 (3), 436-437. https://doi.org/10.1164/ajrccm.182.3.436

114. Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W.,… & Zhang, S. (2020). Coagulopathy and antiphospholipid antibodies in patients with Covid-19. New England Journal of Medicine, 382 (17), e38. https://doi.org/10.1056/NEJMc2007575

115. Levi, M., Nieuwdorp, M., van der Poll, T., & Stroes, E. (2008). Metabolic modulation of inflammation-induced activation of coagulation. In Seminars in thrombosis and hemostasis (Vol. 34, No. 01, pp. 026-032). Thieme Medical Publishers. https://doi.org/10.1055/s-2008-1066020

116. Imai, Y., Kuba, K., Neely, G.G., Yaghubian-Malhami, R., Perkmann, T., van Loo, G.,… & Penninger, J.M. (2008). Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell, 133 (2), 235-249. https://doi.org/10.1016/j.cell.2008.02.043

117. Hamming, I., Timens, W., Bulthuis, M.L.C., Lely, A.T., Navis, G.V., & van Goor, H. (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland, 203 (2), 631-637. https://doi.org/10.1002/path.1570

118. Chen, L., Li, X., Chen, M., Feng, Y., & Xiong, C. (2020). The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS - CoV-2. Cardiovascular research, 116 (6) 1097-1100. https://doi.org/10.1093/cvr/cvaa078

119. CDC Covid-19 Response Team, CDC COVID-19 Response Team, CDC COVID-19 Response Team, Bialek, S., Gierke, R., Hughes, M.,… & Skoff, T. (2020). Coronavirus disease 2019 in children-United States, february 12-april 2, 2020. Morbidity and Mortality Weekly Report, 69 (14), 422-426.

120. Verdoni, L., Mazza, A., Gervasoni, A., Martelli, L., Ruggeri, M., Ciuffreda, M.,… &

D'Antiga, L. (2020). An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. The Lancet, 395 (10239), 1771-1778. https://doi.org/10.1016/S0140-6736 (20) 31103-X

121. Viner, R.M., & Whittaker, E. (2020). Kawasaki-like disease: emerging complication during the COVID-19 pandemic. The Lancet, 395 (10239), 1741-1743. https://doi.org/10.1016/S0140-6736 (20) 31129-6

122. Kato, H., Sugimura, T., Akagi, T., Sato, N., Hashino, K., Maeno, Y.,… & Yamakawa, R. (1996). Long-term consequences of Kawasaki disease: a 10-to 21-year follow-up study of 594 patients. Circulation, 94 (6), 1379-1385. https://doi.org/10.1161/01.CIR.94.6.1379

123. Aykac, K., Ozsurekci, Y., Yayla, B.C.C., Gurlevik, S.L., Oygar, P.D., Bolu, N.B.,… & Ceyhan, M. (2021). Oxidant and antioxidant balance in patients with COVID-19. Pediatric pulmonology, 56 (9), 2803-2810. https://doi.org/10.1002/ppul.25549

124. Cecchini, R., & Cecchini, A.L. (2020). SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Medical hypotheses, 143, 110102. https://doi.org/10.1016/_j.mehy.2020.110102

125. Pincemail, J., Cavalier, E., Charlier, C., Cheramy-Bien, J.P., Brevers, E., Courtois, A., … & Rousseau, A.F. (2021). Oxidative stress status in COVID-19 patients hospitalized in intensive care unit for severe pneumonia. A pilot study. Antioxidants, 10 (2), 257. https://doi.org/10.3390/antiox10020257

126. Karkhanei, B., Ghane, E.T., & Mehri, F. (2021). Evaluation of oxidative stress level: Total antioxidant capacity, total oxidant status and glutathione activity in patients with COVID-19. New Microbes and New Infections, 42, 100897. https://doi.org/10.1016/_j.nmni.2021.100897

127. Gadotti, A.C., Lipinski, A.L., Vasconcellos, F.T., Marqueze, L.F., Cunha, E.B., Campos, A.C.,… & Pinho, R.A. (2021). Susceptibility of the patients infected with Sars-Cov2 to oxidative stress and possible interplay with severity of the disease. Free Radical Biology and Medicine, 165, 184-190. https://doi.org/10.1016/_j.freeradbiomed.2021.01.044

128. Martin-Fernandez, M., Aller, R., Heredia-Rodriguez, M., Gomez-Sanchez, E., Martinez-

Paz, P., Gonzalo-Benito, H.,… & Tamayo-Velasco, A. (2021). Lipid peroxidation as a hallmark of severity in COVID-19 patients. Redox Biology, 48, 102181. https://doi.org/10.1016/_j.redox.2021.102181

129. Sena, C.M., Leandro, A., Azul, L., Seica, R., & Perry, G. (2018). Vascular oxidative stress: impact and therapeutic approaches. Frontiers in physiology, 9, 1668. https://doi.org/10.3389/fphys.2018.01668

130. Suhail, S., Zajac, J., Fossum, C., Lowater, H., McCracken, C., Severson, N.,… & Hati, S. (2020). Role of oxidative stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) infection: a review. The protein journal, 39, 644-656. https://doi.org/10.1007/s10930-020-09935-8

131. Lovren, F., Pan, Y., Quan, A., Teoh, H., Wang, G., Shukla, P.C.,… & Verma, S. (2008). Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. American Journal of Physiology-Heart and Circulatory Physiology, 295 (4), H1377-H1384. https://doi.org/10.1152/ajpheart.00331.2008

132. Daiber, A., Hahad, O., Andreadou, I., Steven, S., Daub, S., & Munzel, T. (2021). Redox - related biomarkers in human cardiovascular disease-classical footprints and beyond. Redox biology, 42, 101875. https://doi.org/10.1016/_j.redox.2021.101875

133. Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021). Broadening horizons: the role of ferroptosis in cancer. Nature reviews Clinical oncology, 18 (5), 280-296. https://doi.org/10.1038/s41571 -020-00462-0

134. Chang, Y.T., Chang, W.N., Tsai, N.W., Huang, C.C., Kung, C.T., Su, Y.J.,… & Lu, C.H. (2014). The roles of biomarkers of oxidative stress and antioxidant in Alzheimer's disease: a systematic review. BioMed research international, 2014. https://doi.org/10.1155/2014/182303

135. Notarnicola, M., Osella, A.R., Caruso, M.G., Pesole, P.L., Lippolis, A., Tutino, V.,… & Messa, C. (2021). Nonalcoholic fatty liver disease: Focus on new biomarkers and lifestyle interventions. International Journal of Molecular Sciences, 22 (8), 3899. https://doi.org/10.3390/ijms22083899

136. Gonzalo Benito, H., Brieva Ruiz, L., Tatzber, F., Jovd Font, M., Cacabelos Barral, D., Cassanyd, A.,… & Portero Otin, M. (2012). Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism. Journal of Neurochemistry, 2012, vol. 123, num. 4, p. 622-634. http://hdl.handle.net/10459.1/58574

137. Paliogiannis, P., Fois, A.G., Sotgia, S., Mangoni, A.A., Zinellu, E., Pirina, P.,… & Zinellu, A. (2018). Circulating malondialdehyde concentrations in patients with stable chronic obstructive pulmonary disease: A systematic review and meta-analysis. Biomarkers in Medicine, 12 (7), 771-781. https://doi.org/10.2217/bmm-2017-0420

138. Chan-Yeung, M., & Xu, R.H. (2003). SARS: epidemiology. Respirology 8 (Suppl): S9- S14.

139. Hoffmann, M., Kleine-Weber, H., Schroeder, S., Kruger, N., Herrler, T., Erichsen, S.,… & Pohlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181 (2), 271-280. https:ZZdoi.org/10.1016Zj.cell.2020.02.052

140. Magalhaes, G.S., Rodrigues-Machado, M.G., Motta-Santos, D., Silva, A.R., Caliari, M.V., Prata, L.O.,… & Campagnole-Santos, M.J. (2015). A ngiotensin - (1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation. British Journal of Pharmacology, 172 (9), 2330-2342. https://doi.org/10.1111/bph.13057

141. Chen, Q., Yang, Y., Huang, Y., Pan, C., Liu, L., & Qiu, H. (2013). Angiotensin - (1-7) attenuates lung fibrosis by way of Mas receptor in acute lung injury. Journal of surgical research, 185 (2), 740-747. https://doi.org/10.1016/jjss.2013.06.052

142. Li, Y., Cao, Y., Zeng, Z., Liang, M., Xue, Y., Xi, C.,… & Jiang, W. (2015). Angiotensin-converting enzyme 2/angiotensin - (1-7)/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF-kB pathways. Scientific reports, 5 (1), 8209. https://doi.org/10.1038/srep08209

143. Meng, Y., Yu, C.H., Li, W., Li, T., Luo, W., Huang, S.,… & Li, X. (2014). Angiotensin-converting enzyme 2/angiotensin - (1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-kB pathway. American journal of respiratory cell and molecular biology, 50 (4), 723-736. https://doi.org/10.1165/rcmb.2012-0451OC

144. Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J.,… & Tummino, P. (2002). Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. Journal of Biological Chemistry, 277 (17), 14838-14843. https://doi.org/10.1074/jbc.M200581200

145. Sodhi, C.P., Wohlford-Lenane, C., Yamaguchi, Y., Prindle, T., Fulton, W.B., Wang, S., … & Jia, H. (2018). Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration. American Journal of Physiology-Lung Cellular and Molecular Physiology, 314 (1), L17-L31. https://doi.org/10.1152/ajplung.00498.2016

146. Fraga-Silva, R.A., Costa-Fraga, F.P., Sousa, F.B.D., Alenina, N., Bader, M., Sinisterra, R.D., & Santos, R.A. (2011). An orally active formulation of angiotensin - (1-7) produces an antithrombotic effect. Clinics, 66, 837-841. https://doi.org/10.1590/S1807 - 59322011000500021

147. Marques, F.D., Ferreira, A.J., Sinisterra, R.D., Jacoby, B.A., Sousa, F.B., Caliari, M.V.,… & Santos, R.A. (2011). An oral formulation of angiotensin - (1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats. Hypertension, 57 (3), 477-483. https://doi.org/10.1161/HYPERTENSIONAHA.110.167346

148. Fraga-Silva, R.A., Pinheiro, S.V.B., Goncalves, A.C.C., Alenina, N., Bader, M., & Souza Santos, R.A. (2008). The antithrombotic effect of angiotensin - (1-7) involves mas-mediated NO release from platelets. Molecular Medicine, 14, 28-35. https://doi.org/10.2119/2007 - 00073. Fraga-Silva

149. Zhang, H., Penninger, J.M., Li, Y., Zhong, N., & Slutsky, A.S. (2020). Angiotensinconverting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive care medicine, 46, 586-590. https://doi.org/10.1007/s00134-020-05985 - 9

150. Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B.,… & Penninger, J.M. (2005). A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nature medicine, 11 (8), 875-879. https://doi.org/10.1038/nm1267

151. Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B.,… & Penninger, J.M. (2005). Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature, 436 (7047), 112116. https://doi.org/10.1038/nature03712

152. Xie, X., Chen, J., Wang, X., Zhang, F., & Liu, Y. (2006). Erratum to «Age-and gender-related difference of ACE2 expression in rat lung». Life Sciences, 26 (79), 2499. http://dx.doi.org/10.1016% 2Fj.lfs.2006.09.028

153. Verdecchia, P., Cavallini, C., Spanevello, A., & Angeli, F. (2020). The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. European journal of internal medicine, 76, 14-20.

154. Zhong, J., Basu, R., Guo, D., Chow, F.L., Byrns, S., Schuster, M.,… & Oudit, G.Y. (2010). Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Circulation, 122 (7), 717-728. https://doi.org/10.1016/j.ejim.2020.04.037

155. Trask, A.J., Averill, D.B., Ganten, D., Chappell, M.C., & Ferrario, C.M. (2007). Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin - (1-7) in transgenic Ren-2 hypertensive rats. American Journal of Physiology-Heart and Circulatory Physiology, 292 (6), H3019-H3024. https://doi.org/10.1152/ajpheart.01198.2006

156. Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID - 19: consider cytokine storm syndromes and immunosuppression // The lancet. 2020. V. 395. №10229. P. 1033-1034. https://doi.org/10.1016/S0140-6736 (20) 30628-0

155. Mehta, P., McAuley, D.F., Brown, M., Sanchez, E., Tattersall, R.S., & Manson, J.J. (2020). COVID-19: consider cytokine storm syndromes and immunosuppression. The lancet, 395 (10229), 1033-1034. https://doi.org/10.1016/S0140-6736 (20) 30628-0

157. Akhmerov, A., & Marban, E. (2020). COVID-19 and the heart. Circulation research, 126 (10), 1443-1455. https://doi.org/10.1161/CIRCRESAHA.120.317055

158. Krivosheev, V.V., & Stolyarov, A.I. (2021). Atmosfernoe davlenie i COVID-19. Sanitarnyi vrach, (7), 8-17. https://doi.org/10.33920/med-08-2107-01

159. Pirouz, B., Shaffiee Haghshenas, S., Shaffiee Haghshenas, S., & Piro, P. (2020).

Investigating a serious challenge in the sustainable development process: analysis of confirmed cases of COVID-19 (new type of coronavirus) through a binary classification using artificial intelligence and regression analysis. Sustainability, 12 (6), 2427. https://doi.org/10.3390/su12062427

160. Adhikari, A., & Yin, J. (2020). Short-term effects of ambient ozone, PM2. 5, and meteorological factors on COVID-19 confirmed cases and deaths in Queens, New York. International journal of environmental research and public health, 77 (11), 4047. https://doi.org/10.3390/ijerph17114047

161. Li, K. (2020). The link between humidity and COVID-19 caused death. Journal of Biosciences and Medicines, 8 (6), 50-55. https://doi.org/10.4236/jbm.2020.86005

162. Bashir, M.F., Ma, B., Komal, B., Bashir, M.A., Tan, D., & Bashir, M. (2020). Correlation between climate indicators and COVID-19 pandemic in New York, USA. Science of the Total Environment, 728, 138835. https://doi.org/10.1016/j.scitotenv.2020.138835

163. Gupta, A., Banerjee, S., & Das, S. (2020). Significance of geographical factors to the COVID-19 outbreak in India. Modeling earth systems and environment, 6, 2645-2653. https://doi.org/10.1007/s40808-020-00838-2

164. Pani, S.K., Lin, N.H., & RavindraBabu, S. (2020). Association of COVID-19 pandemic with meteorological parameters over Singapore. Science of the Total Environment, 740, 140112. https://doi.org/10.1016/j. scitotenv.2020.140112

165. Cai, Q.C., Lu, J., Xu, Q.F., Guo, Q., Xu, D.Z., Sun, Q.W.,… & Jiang, Q.W. (2007). Influence of meteorological factors and air pollution on the outbreak of severe acute respiratory syndrome. Public health, 121 (4), 258-265. https://doi.org/10.1016/j.puhe.2006.09.023

166. Kumar, G., & Kumar, R.R. (2020). A correlation study between meteorological parameters and COVID-19 pandemic in Mumbai, India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14 (6), 1735-1742. https://doi.org/10.1016/j.dsx.2020.09.002

167. Deyal, N., Tiwari, V., & Bisht, N. (2020). Impact of climatic parameters on COVID-19 pandemic progression in India: analysis and prediction. https://doi.org/10.1101/2020.07.25.20161919

168. Leung, N.Y., Bulterys, M.A., & Bulterys, P.L. (2020). Predictors of COVID-19 incidence, mortality, and epidemic growth rate at the country level. MedRxiv, 2020-05. https://doi.org/10.1101/2020.05.15.20101097

169. Jaakkola, K., Saukkoriipi, A., Jokelainen, J., Juvonen, R., Kauppila, J., Vainio, O.,… & KIAS-Study Group. (2014). Decline in temperature and humidity increases the occurrence of influenza in cold climate. Environmental Health, 13, 1-8. https://doi.org/10.1186/1476-069X-13-22

170. Liu, J., Zhou, J., Yao, J., Zhang, X., Li, L., Xu, X.,… & Zhang, K. (2020). Impact of meteorological factors on the COVID-19 transmission: A multi-city study in China. Science of the total environment, 726, 138513. https://doi.org/10.1016/j.scitotenv.2020.138513

171. Luo, W., Majumder, M.S., Liu, D., Poirier, C., Mandl, K.D., Lipsitch, M., & Santillana, M. (2020). The role of absolute humidity on transmission rates of the COVID-19 outbreak. MedRxiv, 2020-02. https://doi.org/10.1101/2020.02.12.20022467

172. Briz-Redon, A., & Serrano-Aroca, A. (2020). A spatio-temporal analysis for exploring the effect of temperature on CO VID-19 early evolution in Spain. Science of the total environment, 728, 138811. https://doi.org/10.1016/_j.scitotenv.2020.138811

Размещено на Allbest.ru